The relationship between dopamine receptor blockade and cognitive performance in schizophrenia: a [11C]-raclopride PET study with aripiprazole
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The relationship between dopamine receptor blockade and cognitive performance in schizophrenia: a [11C]-raclopride PET study with aripiprazole
Authors
Keywords
-
Journal
Translational Psychiatry
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-18
DOI
10.1038/s41398-018-0134-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insight into illness and its relationship to illness severity, cognition and estimated antipsychotic dopamine receptor occupancy in schizophrenia: An antipsychotic dose reduction study
- (2017) Philip Gerretsen et al. PSYCHIATRY RESEARCH
- Placebo Response and Practice Effects in Schizophrenia Cognition Trials
- (2017) Richard S. E. Keefe et al. JAMA Psychiatry
- An investigation into aripiprazole’s partial D2 agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteers
- (2016) Anna Murphy et al. PSYCHOPHARMACOLOGY
- Alterations in cortical and extrastriatal subcortical dopamine function in schizophrenia: systematic review and meta-analysis of imaging studies
- (2014) Joseph Kambeitz et al. BRITISH JOURNAL OF PSYCHIATRY
- A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults
- (2014) Leslie Citrome et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Longitudinal Course of Cognitive Impairment in Schizophrenia
- (2014) Richard S. E. Keefe JOURNAL OF CLINICAL PSYCHIATRY
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
- (2012) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Effect of Aripiprazole on Verbal Memory and Fluency in Schizophrenic Patients
- (2012) Chris Bervoets et al. CNS DRUGS
- Cognitive Effects of a Single Dose of Atypical Antipsychotics in Healthy Volunteers Compared With Placebo or Haloperidol
- (2012) Young-Chul Chung et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients
- (2012) Hikaru Hori et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory
- (2012) Euitae Kim et al. PSYCHOPHARMACOLOGY
- Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data
- (2012) Hitoshi Sakurai et al. SCHIZOPHRENIA BULLETIN
- Calculating Occupancy when One does not have Baseline: A Comparison of Different Options
- (2011) Euitae Kim et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients
- (2011) Norio Yasui-Furukori et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The effects of acute treatment with tandospirone, diazepam, and placebo on driving performance and cognitive function in healthy volunteers
- (2010) Masahiro Takahashi et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Effect of Aripiprazole on Cognition in the Treatment of Patients with Schizophrenia
- (2010) M. Riedel et al. PHARMACOPSYCHIATRY
- An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia
- (2010) Hidenobu Suzuki et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Switching schizophrenia patients from typical neuroleptics to aripiprazole: Effects on working memory dependent functional activation
- (2010) Florian Schlagenhauf et al. SCHIZOPHRENIA RESEARCH
- Effectiveness of Switching to Aripiprazole From Atypical Antipsychotics in Patients With Schizophrenia
- (2009) Sung-Wan Kim et al. CLINICAL NEUROPHARMACOLOGY
- Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
- (2009) O. Howes et al. CURRENT PHARMACEUTICAL DESIGN
- D2 Receptor Blockade by Risperidone Correlates With Attention Deficits in Late-Life Schizophrenia
- (2009) Hiroyuki Uchida et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Dose–Occupancy Study of Striatal and Extrastriatal Dopamine D2 Receptors by Aripiprazole in Schizophrenia with PET and [18F]Fallypride
- (2008) Lawrence S Kegeles et al. NEUROPSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started